These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15577250)

  • 21. Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety.
    Seto M; Aikawa K; Miyamoto N; Aramaki Y; Kanzaki N; Takashima K; Kuze Y; Iizawa Y; Baba M; Shiraishi M
    J Med Chem; 2006 Mar; 49(6):2037-48. PubMed ID: 16539392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4.
    Hashimoto C; Nomura W; Narumi T; Fujino M; Tsutsumi H; Haseyama M; Yamamoto N; Murakami T; Tamamura H
    ChemMedChem; 2013 Oct; 8(10):1668-72. PubMed ID: 24039179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
    Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
    Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.
    Khurana S; Kennedy M; King LR; Golding H
    J Virol; 2005 Jun; 79(11):6791-800. PubMed ID: 15890918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134.
    Kanbara K; Sato S; Tanuma J; Tamamura H; Gotoh K; Yoshimori M; Kanamoto T; Kitano M; Fujii N; Nakashima H
    AIDS Res Hum Retroviruses; 2001 May; 17(7):615-22. PubMed ID: 11375057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and HIV inhibition activity of 2',3'-dideoxy-3'-C-hydroxymethyl nucleosides.
    Lee-Ruff E; Ostrowski M; Ladha A; Stynes DV; Vernik I; Jiang JL; Wan WQ; Ding SF; Joshi S
    J Med Chem; 1996 Dec; 39(26):5276-80. PubMed ID: 8978856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HIV-1 activity of pyrryl aryl sulfone (PAS) derivatives: synthesis and SAR studies of novel esters and amides at the position 2 of the pyrrole nucleus.
    Silvestri R; Artico M; La Regina G; De Martino G; La Colla M; Loddo R; La Colla P
    Farmaco; 2004 Mar; 59(3):201-10. PubMed ID: 14987983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of some pyridine ribosides and their biological activity.
    Attia AM; Mansour HA; Almehdi AA; Abbasi MM
    Nucleosides Nucleotides; 1999 Oct; 18(10):2301-6. PubMed ID: 10616731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1.
    Tallant MD; Duan M; Freeman GA; Ferris RG; Edelstein MP; Kazmierski WM; Wheelan PJ
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1394-8. PubMed ID: 21292480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite.
    Nishizawa R; Nishiyama T; Hisaichi K; Matsunaga N; Minamoto C; Habashita H; Takaoka Y; Toda M; Shibayama S; Tada H; Sagawa K; Fukushima D; Maeda K; Mitsuya H
    Bioorg Med Chem Lett; 2007 Feb; 17(3):727-31. PubMed ID: 17118654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling.
    Vyroubalova EC; Hartley O; Mermod N; Fisch I
    Mol Immunol; 2006 Apr; 43(10):1573-8. PubMed ID: 16280164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of RANTES by extracellular parts of the CCR5 receptor.
    Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
    J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
    Dragic T; Trkola A; Thompson DA; Cormier EG; Kajumo FA; Maxwell E; Lin SW; Ying W; Smith SO; Sakmar TP; Moore JP
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5639-44. PubMed ID: 10779565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new cadinane sesquiterpene with significant anti-HIV-1 activity from the cultures of the basidiomycete Tyromyces chioneus.
    Liu DZ; Wang F; Yang LM; Zheng YT; Liu JK
    J Antibiot (Tokyo); 2007 May; 60(5):332-4. PubMed ID: 17551214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain.
    Casimiro-Garcia A; De Clercq E; Pannecouque C; Witvrouw M; Stup TL; Turpin JA; Buckheit RW; Cushman M
    Bioorg Med Chem; 2000 Jan; 8(1):191-200. PubMed ID: 10968278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase.
    Sun Y; Xu W; Fan N; Sun X; Ning X; Ma L; Liu J; Wang X
    Bioorg Med Chem; 2017 Feb; 25(3):1076-1084. PubMed ID: 28082070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on CCR5 analogs and affinity peptides.
    Wu Y; Deng R; Wu W
    Protein Eng Des Sel; 2012 Mar; 25(3):97-105. PubMed ID: 22238429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.
    Abayev M; Moseri A; Tchaicheeyan O; Kessler N; Arshava B; Naider F; Scherf T; Anglister J
    FEBS J; 2015 May; 282(10):1906-1921. PubMed ID: 25703038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
    Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
    Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.